Premium
Anti‐Androgens in Treatment of Acne Vulgaris
Author(s) -
Amer Mohamed,
Ramadan Ali,
Monem Ahmed Abdel
Publication year - 1985
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4362.1985.tb05840.x
Subject(s) - acne , cyproterone acetate , medicine , dermatology , cyproterone , antiandrogen , gynecology , androgen , hormone
Seventy‐five women suffering from acne vulgaris classified into three groups according to the grade of the disease. Anti‐androgenic tablets cyproterone acetate (CPA), were given in three cycles. The total number of patients whose condition improved was 52% after the first cycle, 55% after the second cycle, and 81.3% after the third cycle. No serious side effects were encountered. CPA is a suitable therapeutic modility for AV in women who use contraceptives.